Compare · head to head
Hansoh Pharmaceutical vs Takeda Pharmaceutical
Hansoh Pharmaceutical ranks higher overall — 360 rank 66 vs 48.
Takeda Pharmaceutical leads on Value (68 vs 37) and Sentiment (65 vs 50). Hansoh Pharmaceutical leads on Quality (59 vs 44) and Safety (69 vs 22). The two are close on Growth.
Ranks as of 2026-06-12 · 1–100 vs true peers. Higher is better.
| Compare | ||
|---|---|---|
| Profile | ||
| Country | Hong Kong SAR China | Japan |
| Sector | Health Care | Health Care |
| Industry | Pharmaceuticals | Pharmaceuticals |
| Size | Large | XX-Large |
| ISIN | KYG549581067 | JP3463000004 |
| Last update | 2026-04-02 | 2026-04-02 |
| History | ||
| 360 (V1) since 2023 | ||
| Ranks | ||
| 360 | 66 | 48 |
| Value | 37 | 68 |
| Quality | 59 | 44 |
| Growth | 50 | 49 |
| Safety | 69 | 22 |
| Sentiment | 50 | 65 |
| Quality details | ||
| Profitability | 71 | 12 |
| Cash Truth | 48 | 76 |
Hansoh Pharmaceutical vs CSPC PharmaceuticalHansoh Pharmaceutical vs HUTCHMED (China)Hansoh Pharmaceutical vs Aprogen BiologicsHansoh Pharmaceutical vs Dongwha PharmAdd a third stock →
Full analyses: Hansoh Pharmaceutical · Takeda Pharmaceutical
Make Sense of the Ranks
Every rank runs 1–100 against true peers. Higher is always better.
360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100